Discover Cutting-Edge Research

Access thousands of peer-reviewed articles, submit your research, and join a global community of scholars advancing knowledge.

Browse Articles Submit Article

21+

Published Articles

8.7

Our Rating

Registered Authors

50+

Countries

Welcome to AJPCR (Online ISSN: 2455-3891 | Print ISSN: 0974-2441)

Focus and Scope:

AJPCR (Asian J Pharm Clin Res) started in 2008 and is a peer-reviewed monthly (Onward Jan 2017) open access Journal. The journal publishes original research in Pharmaceutical Sciences and Clinical Sciences. The Journal has been designed to cover all the fields of research, which has any correlation and impact on Pharmaceutical Science and clinical research (Pharmacognosy, Natural Products, Pharmaceutics, Novel Drug Delivery, Pharmaceutical Technology, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry, Drug Design, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical Pharmacy, Pharmaceutical Biotechnology and Pharmaceutical Microbiology, Medical Sciences). AJPCR publishes original research Articles or as a Short Communication for original research work. The journal publishes Reviews to keep readers up to speed with the latest advances across diverse current scientific topics on under mentioned scopes are also considered for publication. In addition, a case report is also invited now for publication.

Abstracting and Indexing:

Google Scholar, Scopus, Elsevier Products (EMBASE), CNKI (China Knowledge Resource Integrated Database), CAS, CASSI (American Chemical Society), Scientific Commons, Open-J-Gate, Index Medicus for WHO South-East Asia (IMSEAR), OAI, LOCKKS, OCLC (World Digital Collection Gateway), UIUC.

Announcements

August 1, 2025

Exciting news!

AJPCR Scopus indexing continues in 2025, followed by 2024, enhancing our visibility and impact in the academic community.

July 1, 2025

Exciting news!

AJPCR Scopus indexing continues in 2025, followed by 2024, enhancing our visibility and impact in the academic community.

Latest Research

Discover the newest published articles

Antiviral Drug Development for Emerging Viruses

Emerging viruses like SARS-CoV-2 and Ebola necessitate rapid antiviral drug development. Strategies include targeting viral replication (e.g., protease inhibitors) and host immune responses. Remdesivir and molnupiravir, developed for COVID-19, exemplify broad-spectrum antivirals. Challenges include viral mutations and lengthy clinical trials. High-throughput screening and AI-driven drug design accelerate discovery. Future efforts focus on pan-viral therapies effective against multiple virus families.

By SREENU THALLA , Ashish Vishwakarma, KAVITA A

antiviral drugs emerging viruses drug discovery

Jul 28, 2025

AI in Medical Diagnostics

Artificial Intelligence (AI) enhances medical diagnostics by analyzing imaging, genetic, and clinical data with high accuracy. Deep learning models detect abnormalities in X-rays, MRIs, and pathology slides, aiding in early diagnosis of diseases like cancer and Alzheimer’s. AI also predicts patient outcomes using electronic health records. Challenges include data privacy, algorithmic bias, and regulatory approval. Explainable AI and integration with clinical workflows are key research areas. AI’s role in telemedicine is expanding access to diagnostics.

By Ashish Vishwakarma

AI medical diagnostics deep learning

Jul 28, 2025

Regenerative Medicine: Stem Cell Therapies

Regenerative medicine uses stem cells to repair or replace damaged tissues, offering hope for conditions like heart disease and spinal cord injuries. Induced pluripotent stem cells (iPSCs) are reprogrammed from adult cells, avoiding ethical issues of embryonic stem cells. Clinical trials show promise in treating macular degeneration and heart failure. Challenges include immune rejection and tumorigenic risks. Advances in 3D bioprinting and gene editing enhance precision and efficacy.

By Ashish Vishwakarma

stem cells regenerative medicine iPSCs

Jul 28, 2025

Ready to Share Your Research?

Join thousands of researchers who trust OpenJournal to publish their groundbreaking work.